Related Experiment Video
Updated: May 8, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Basics of compounding; considerations for implementing United States pharmacopeia chapter 797 pharmaceutical
Loyd V Allen1, Claudia C Okeke
1International Journal of Pharmaceutical Compounding, Edmond, Oklahoma.
Abstract:
A compounding facility, including the staff, bears the responsibility of ensuring that any potential soucre of contamination has been considered, properly addressed, and documented. Therefore, the design of the compounding facility must consider the (1)potential for airborne contamination, (2)work flow, (3)efficiency, and (4)personnel comfort. The understanding of a critical site, which is any location that is exposed and can allow intrusion of microorganisms and/or foreign matter, and the nature of the critical site and exposure is paramount in the compounding of sterile preparations. This means that not only the design of the facility must be considered but standard operating procedures must be in place for personnel, and those procedures must be strictly adhered to. This article emphasizes the improtance of considering the critical site during compounding procedures, the design and rationale supporting the facility, and operational activities surrounding active compounding.
Related Concept Videos
Dosage Regimen: Individualization
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Dosage Regimens: Designs and Approaches
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

